CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

163 hedge funds and large institutions have $1.48B invested in Celldex Therapeutics in 2014 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+15
Holders Change %
+10.14%
% of All Funds
4.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
63
Reduced
36
Closed
18
Calls
$19.3M
Puts
$36.9M
Net Calls
-$17.6M
Net Calls Change
-$16.2M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$245M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$48.7M
3
VOYA Investment Management
3
VOYA Investment Management
Georgia
$12.2M
4
CCI
4
Columbus Circle Investors
$29.7M
5
O
5
OppenheimerFunds
New York
$170M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$0
2
Franklin Resources
2
Franklin Resources
California
$175M
3
TCMG
3
TSP Capital Management Group
New Jersey
$15.4M
4
AAP
4
Ardsley Advisory Partners
Connecticut
$0
5
CWAM
5
Columbia Wanger Asset Management
Illinois
$58.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
DTL
176
Dynamic Technology Lab
Singapore
– -$140K -720 Closed
HCM
177
Highlander Capital Management
New Jersey
– -$90.7K -467 Closed
JT
178
Jump Trading
Illinois
– -$24K -125 Closed
Fifth Third Bancorp
179
Fifth Third Bancorp
Ohio
– -$2K -9 Closed
PTC
180
Private Trust Company
Ohio
– -$1K -4 Closed
4 5 6 7
8